Stock Analiz

Rapid Micro Biosystems, Inc. RPID

Biotechnology: Laboratory Analytical Instruments · IPO 2021 · data as of November 13, 2026

$0.65Market cap $33M
Open the interactive analysis →

Rapid Micro Biosystems, Inc. (RPID) is a industrial company listed in the US with a market value of about $33M. In the twelve months to June 30, 2026 it had revenue of $35M and net income of -$51M, a net margin of -145.6%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 16% a year, a 5-year average ROIC of -41%.

About Rapid Micro Biosystems

Rapid Micro Biosystems is listed in the US and classified in biotechnology: laboratory analytical instruments, IPO year 2021. Revenue went from $16M in 2020 to $34M in 2025, growth of about 15.9% a year. It was profitable in 0 of the last 6 years in our data. Its share count rose by 5% over three years (dilution for shareholders). It spends 41% of revenue on research and development.

Score: 1.2 / 5

Value0/5
Future growth4/5
Track record1/5
Financial health1/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.9
P/B1.8
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-123.7%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)19.7%
Revenue growth (5 yrs, per year)15.9%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-242.4%
ROIC (5-yr avg.)-40.7%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 6 years

Fiscal yearTTM202520242023202220212020
Revenue$35M$34M$28M$23M$17M$23M$16M
Net income-$51M-$47M-$47M-$52M-$61M-$74M-$37M
Free cash flow-$40M-$32M-$46M-$47M-$65M-$58M-$32M
EPS (diluted)$-1.11$-1.05$-1.08$-1.22$-1.43$-3.94$-126.11
Net margin-145.6%-140.3%-167.2%-233.0%-354.9%-316.5%-230.6%
ROIC—-65.8%-48.5%-35.7%-36.4%-16.9%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Rapid Micro Biosystems pay a dividend?

Not currently.

Is Rapid Micro Biosystems a good stock to buy?

We do not give buy or sell advice. Rapid Micro Biosystems scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.